Blue Turtle Bio Competitors and Similar CompaniesClear all
Q32 Bio's competitors and similar companies include Bit Bio and Adhesion Therapeutics.
 Q32 Bio Q32 Bio is a biotechnology company developing treatments for patients with severe autoimmune and inflammatory diseases. |  Adhesion Therapeutics Adhesion Therapeutics (also known as Celeris Therapeutics) is a company that designs molecular glue degraders. | ||
Founding Date | Founding Date N/A | Founding Date 2016 | Founding Date 2021 |
Type | Type Private | Type Private | Type Private |
Tags | |||
Locations | Locations Cambridge, US HQ | Locations Babraham, GB HQ Histon, GB | Locations Menlo Park, US HQ Graz, AT London, GB |
Employees | Employees 348% decrease | Employees 1644% decrease | Employees 433% decrease |
Funding | |||
Latest funding round | Latest funding round $ 60m (over 5 years ago) | Latest funding round $ 41.5m (almost 6 years ago) | Latest funding round N/A |
Total funding raised | Total funding raised $ 106m | Total funding raised $ 41.5m | Total funding raised N/A |
For sources of this data, please see the company profile
View Company Profiles
Bit Bio
HQ
Babraham, GB
Employees
164↓ 4% decrease
Bit Bio is a company that develops a cell reprogramming platform.
View companyAdhesion Therapeutics
HQ
Menlo Park, US
Employees
4↓ 33% decrease
Adhesion Therapeutics (also known as Celeris Therapeutics) is a company that designs molecular glue degraders.
View company